Suprachiasmatic nucleus-mediated glucose entry into the arcuate nucleus determines the daily rhythm in blood glycemia

Curr Biol. 2022 Feb 28;32(4):796-805.e4. doi: 10.1016/j.cub.2021.12.039. Epub 2022 Jan 13.

Abstract

Glycemia is maintained within very narrow boundaries with less than 5% variation at a given time of the day. However, over the circadian cycle, glycemia changes with almost 50% difference. How the suprachiasmatic nucleus, the biological clock, maintains these day-night variations with such tiny disparities remains obscure. We show that via vasopressin release at the beginning of the sleep phase, the suprachiasmatic nucleus increases the glucose transporter GLUT1 in tanycytes. Hereby GLUT1 promotes glucose entrance into the arcuate nucleus, thereby lowering peripheral glycemia. Conversely, blocking vasopressin activity or the GLUT1 transporter at the daily trough of glycemia increases circulating glucose levels usually seen at the peak of the rhythm. Thus, biological clock-controlled mechanisms promoting glucose entry into the arcuate nucleus explain why peripheral blood glucose is low before sleep onset.

Keywords: arcuate nucleus; blood-brain barrier; glucose rhythm; hypothalamus; tanycytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arcuate Nucleus of Hypothalamus*
  • Blood Glucose
  • Circadian Rhythm
  • Glucose Transporter Type 1
  • Glucose*
  • Suprachiasmatic Nucleus
  • Vasopressins

Substances

  • Blood Glucose
  • Glucose Transporter Type 1
  • Vasopressins
  • Glucose